Long hold plans (months to years) for every stock of the list: an accumulation zone with a buy-by time, average-down levels, sell points with dates, a weekly-close stop and the sell warnings. Watch list biotech_pharma of openstock, 3 stocks.
Updated 2026-10-30 21:30:02 ET · times are US Eastern
Price 16.03 · fundamentals 40/100 · cap 12.23B · 57% under its 5y high · 0.99x the 200 day · 1y vs SPY -23%
No entry plan: Score 40: weak fundamentals, value or health
If you hold it
TRIM Two weekly closes under the 50 week average: the long trend is turning down since Fri Oct 30 2026 16:00 ET
fundamentals 40/100 (weak); 57% under its 5 year high; 0.99x the 200 day average; 1y -23% vs SPY; trend +75% a year; At risk: Altman Z'' under 1.1 (-10.55); warning signs: Negative EBITDA and free cash flow
Price 1.00 · fundamentals 35/100 · cap 15.68M · 99% under its 5y high · 0.73x the 200 day · 1y vs SPY -53%
No entry plan: Fundamentals score 35: weak fundamentals
If you hold it
SELL Fundamentals score fell to 35: the company no longer qualifies since Fri Oct 30 2026 16:00 ET
TRIM Two weekly closes under the 50 week average: the long trend is turning down since Fri Oct 30 2026 16:00 ET
fundamentals 35/100 (weak); 99% under its 5 year high; 0.73x the 200 day average; 1y -53% vs SPY; trend -50% a year; At risk: Altman Z'' under 1.1 (-19.88); warning signs: Negative EBITDA and free cash flow, Market cap under $25M
FAM long hold score 0-100: company fundamentals 50 (profitability, valuation, financial health, growth, analyst view), value 20 (under the 5 year high, price against the 200 day average), health 30 (200 day and 50 week averages, weekly RSI, a year vs SPY, trend line). Rating: BUY (accumulate now), ACCUMULATE (a good company, but stretched: the zone waits near the 200 day average), WATCH (limited data, overheated, a downtrend or a low score), AVOID (weak fundamentals or a toxic asset). Open the fundamentals report of a stock for every check. Warnings: SELL sells what is left now, TRIM takes some profit, WATCH is a heads up. After a stop or a sell signal a stock sits out for 14 days. Not financial advice.
OSA FAM (Open Stock Analysis Fundamental Analysis Model) by Datareel Software Development. Rules based estimate from public market data. It is not financial advice and it cannot foresee news or events that move a stock. Do your own research.
Analytics cookies
With your permission this site uses Google Analytics cookies to count visits and see which pages
are used. Nothing is loaded unless you accept. See the privacy policy.
